Results 131 to 140 of about 4,490 (182)

Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges. [PDF]

Curr Oncol
Habib R, Arnold E, Obi T, Vizeacoumar FJ, Ahmed S.   +4 more
europepmc   +1 more source

Age-stratified adverse-event reporting signals of seven ALK/ROS1 tyrosine kinase inhibitors in FAERS: a disproportionality and time to onset study. [PDF]

Front Pharmacol
Liu Y, Yu Y, Yu Y, Huang X, Zhong H.
europepmc   +1 more source

How to manage radioiodine-refractory thyroid cancer in the era of precision medicine. [PDF]

Drugs Context
Karapanou O, Effraimidis G, Michalaki M, Saltiki K.   +3 more
europepmc   +1 more source

<i>NTRK1-3</i> fusions in sarcomas: prevalence, significance, and clinical implications - a systematic review. [PDF]

Future Oncol
Hamran S, Alnoubani Z, Hassan AM, Al-Rajhi AA, Rajha HE, Altaissan M, Babu GR, Gatalica Z, Vranić S.   +8 more
europepmc   +1 more source

TRK inhibitors in pediatric gliomas. [PDF]

Neurooncol Adv
Perreault S, Doz F.
europepmc   +1 more source

Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies. [PDF]

Cancers (Basel)
Jones DT, Nanda RK, Hussain AA, Hattin R, Myat YM, Thawani R, Cetnar J, Shanshal M, Thein KZ, Kummar S.   +9 more
europepmc   +1 more source

Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer. [PDF]

EClinicalMedicine
Hulskotte LMG, Veerman GDM, Lanser DAC, Reyners AKL, van Schaik RHN, Dingemans AC, Taxis K, Mathijssen RHJ, Jansman FGA.   +8 more
europepmc   +1 more source

Acquired MTAP Loss Following Entrectinib Resistance in ROS1-Rearranged NSCLC With CD74 Exon 3-ROS1 Exon 34 Fusion. [PDF]

Thorac Cancer
Haraguchi Hashiguchi M, Tanino M, Yoneda S, Asaoka M, Kagyo J, Katayama M, Terai H, Nakamura K, Nishihara H, Fukunaga K.   +9 more
europepmc   +1 more source

Real-World Treatment Patterns and Survival in Patients with <i>ROS1</i>-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe. [PDF]

Curr Oncol
Cheung WY, Lee A, Bote de Cabo H, Burdenski K, Christopoulos P, Pinto-Correia B, Deshayes S, Girard N, Hindocha P, Madden Á, Mella M, Moreira J, Rizzi S, Abreu DR, Soares M, Thomas J, Han M, Calvet CY, Emanuel G, Glassberg MB, Jacobs H, Rault C, Yuan Y, Chouaid C.   +23 more
europepmc   +1 more source

Research progress of small molecule targeted drugs for non-small cell lung cancer. [PDF]

Front Oncol
Qiu T, Huang X.
europepmc   +1 more source